ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 759016 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 759016; 2) Community: the network communities that were significantly associated with the response to NSC 759016; 3) Molecule: the relationships between components within communities and NSC 759016; 4) MDR: the compounds that were significantly associated with the NSC 759016.

NSC Compound Enrichment Correlation
NSC 760016 (E)-3-(3,5-dimethoxyphenyl)-1-(4-(quinazolin-4-ylamino)phenyl)prop-2-en-1-one 0.0352786308082228 0.414664
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0378615809326463 0.34353304
NSC 129757 Null 0.0378615809326463 0.057337413
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0378615809326463 0.26000348
NSC 244404 Null 0.0378615809326463 0.28661217
NSC 303861 L-Cysteine analog 0.0378615809326463 0.47791882
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0378615809326463 0.34936612
NSC 339137 PHYSALOLACTONE 0.0378615809326463 0.40524769
NSC 39215 Null 0.0378615809326463 0.26778006
NSC 624657 ANTINEOPLASTIC-624657 0.0378615809326463 0.18546251
Total:89  Current:71    [First] [Prev] [Next] [Last]